Innoscripta SE Financial Update

Innoscripta SE, a company listed on the Frankfurt Stock Exchange, has experienced significant market activity recently. As of June 18, 2025, the company’s share price closed at 85.6 EUR, marking both the 52-week low and the close price for the day. This is a notable decline from the 52-week high of 120 EUR, achieved on May 22, 2025.

Börsengang and Market Reaction

Innoscripta SE went public on May 23, 2025, without a capital increase, as existing shareholders sold their shares. The initial placement price was set at 120 EUR per share. However, the stock price quickly fell below 110 EUR on the first trading day and has since declined to around 85 EUR, as reported by 4investors on June 17, 2025.

Founders’ Intervention

In response to the declining share price, the founders of Innoscripta SE have announced plans to make selective share purchases to support the stock price. This initiative, detailed in multiple announcements on June 17, 2025, by sources such as finanznachrichten.de and eqs-news.com, aims to stabilize the market value of the company’s shares. The two primary shareholders, Michael Hohenester and another unnamed founder, are leading this effort.

Recent Transactions

On June 18, 2025, two significant transactions were disclosed. Hohenester Beteiligungs-UG (haftungsbeschränkt) and Meyer Beteiligungs-UG (haftungsbeschränkt) both executed buy transactions. These transactions were publicly disclosed as part of the company’s commitment to transparency regarding trades by managerial personnel and their closely associated individuals.

Conclusion

Innoscripta SE is navigating a challenging period following its IPO, with founders actively working to bolster the share price through strategic purchases. The company’s recent transactions and the founders’ intervention highlight ongoing efforts to stabilize and potentially enhance shareholder value.